Clinical Trial Update: Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. [NA]

View source ↗

Summary

This clinical trial aims to identify fecal microbiota biomarkers of spondyloarthritis in patients with Crohn's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Spondyloarthritis

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Crohn Disease, Spondyloarthritis | NA | Status: RECRUITING